Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models

Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models

Gait analysis could be used in animal models as an indicator of sensory ataxia due to chemotherapy-induced peripheral neurotoxicity (CIPN). Over the years, gait analysis in in vivo studies has evolved from simple observations carried out by a trained operator to computerised systems with machine lea...

Full description

Bibliographic Details
Main Authors:	Maria Lopez-Garzon, Annalisa Canta, Alessia Chiorazzi, Paola Alberti
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Brain Research Bulletin
Subjects:	Chemotherapy-induced peripheral neuropathy Chemotherapy-induced peripheral neurotoxicity Gait analysis Animal models Sensory ataxia Physical therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0361923023001946

Similar Items

Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity
by: Eleonora Pozzi, et al.
Published: (2023-01-01)

Mechanisms of Chemotherapy-Induced Neurotoxicity
by: Halina Was, et al.
Published: (2022-03-01)

Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01)

PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy
by: Christele Le Gouill-Jaijarat, et al.
Published: (2023-01-01)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
by: Sonoko Misawa, et al.
Published: (2023-11-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Study on the Efficacy and Safety of the Huangqi Guizhi Wuwu Decoction in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Meta-Analysis of 32 Randomized Controlled Trials
by: Yang XR, et al.
Published: (2024-08-01)

A HOME-BASED EXERCISE PROGRAM TO IMPROVE NEUROMUSCULAR AND SPATIO-TEMPORAL GAIT PARAMETERS IN A MULTIPLE MYELOMA CANCER SURVIVOR WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: A CASE REPORT
by: Timothy F. Marshall, et al.
Published: (2019-08-01)

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-02-01)

Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment
by: Timothy F. Marshall, et al.
Published: (2017-12-01)

Activating autophagy improves paclitaxel-induced peripheral neuropathy in chemotherapy
by: Jin Zhang, et al.
Published: (2024-10-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Frequency of chemotherapy Induced Gait Deviations in Breast Cancer Female Survivors
by: Fatima Zahid, et al.
Published: (2024-12-01)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
by: Grammatico S, et al.
Published: (2016-06-01)

Bortezomib-induced neurotoxicity in human neurons is the consequence of nicotinamide adenine dinucleotide depletion
by: Andrew R. Snavely, et al.
Published: (2022-12-01)

Exploring social determinants of health on chemotherapy-induced peripheral neuropathy severity in ovarian cancer: An integrative review
by: Chisom O. Odii, et al.
Published: (2024-10-01)

Chemotherapy-Induced Peripheral Neurotoxicity as A Risk Factor for Poor Sleep Quality in Breast Cancer Survivors Treated with Docetaxel
by: Ya-Ning Chan, et al.
Published: (2021-01-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
by: Xiaoli Lv, et al.
Published: (2023-03-01)

Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members
by: Sardo S, et al.
Published: (2023-09-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
by: Patricia Teran-Wodzinski, et al.
Published: (2022-04-01)

Neuroinflammation and сhemotherapy-induced peripheral neuropathy
by: P. I. Pilipenko, et al.
Published: (2022-04-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, randomized trial
by: Christine Brunner, et al.
Published: (2024-08-01)

Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment
by: Marina Mattar, et al.
Published: (2024-08-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy
by: Ju Hyeon Jeong, et al.
Published: (2013-12-01)

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
by: Mitsuru Sugimoto, et al.
Published: (2021-12-01)

Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
by: Jordi Bruna, et al.
Published: (2018-01-01)

A new approach to characterize postural deficits in chemotherapy-induced peripheral neuropathy and to analyze postural adaptions after an exercise intervention
by: Sarah Kneis, et al.
Published: (2020-01-01)

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
by: Nobuaki Egashira
Published: (2021-12-01)

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
by: Andreas A. Argyriou
Published: (2015-05-01)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01)

The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial
by: Kaiyin Chan, et al.
Published: (2020-01-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

The role of physical activity against chemotherapy-induced peripheral neuropathy: a narrative review
by: Daniele Diotti, et al.
Published: (2022-04-01)

Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
by: Yutaka Torii, et al.
Published: (2025-02-01)